youtube_live
Q1 2026 कमाई • रिलीझ केला आहे • EPS अपेक्षेहून जास्त आहे +७०.१८% • महसूल अपेक्षेहून जास्त आहे +६४.५८%
परिणाम पहाchevron_right
MRNA:NASDAQ
Moderna Inc
$४७.२१
arrow_upward
+४.०६%(+१.८४) 1D
४ मे, ३:५७:४९ PM [GMT]-४ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | किंमत | बदल | % बदल |
|---|
insights_autoMRNA साठी टॉप इनसाइट जनरेट करत आहे...
उघडा
$४५.३२
उच्च
$४७.९६
कमी
$४५.२९
मार्केट कॅप
१८.६२ अब्ज
सरासरी उलाढाल
६०.५५ लाख
उलाढाल
४६.६८ लाख
५२ आठवड्यांतील उच्चांक
$५९.५५
५२ आठवड्यांतील नीचांक
$२२.२८
EPS
-$८.१५
बीटा
१.०५
थकित शेअर
३९.६६ कोटी
कर्मचाऱ्यांची संख्या
५ ह
बातम्यांच्या स्टोरी
संपूर्ण वेबवरील स्रोतांकडून
TipRanks
·
२ तासांपूर्वी
Why Moderna Stock Is Quietly Powering Higher Now
Yahoo Finance
·
५ तासांपूर्वी
Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era
Seeking Alpha
·
७ तासांपूर्वी
Moderna Stock Analysis: Cash Burn, Pipeline Risks & What's Next
Zacks Investment Research
·
११ तासांपूर्वी
The Zacks Analyst Blog Highlights Moderna, Merck and Vertex Pharmaceuticals
प्रोफाइल
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine, marketed as Spikevax and a respiratory syncytial virus vaccine, marketed as Mresvia. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines. Wikipedia
Moderna Inc बद्दल
AI आशयामध्ये चुका असू शकतात. अधिक जाणून घ्या